CFDE Data Portal | Search BAAT

	Label	Description
	BAAT associations Collection (Entity type)	Associations for BAAT_associations
	BAAT associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	BAAT Gene (Entity type)	ENSG00000136881 - bile acid-CoA:amino acid N-acyltransferase
	BAAT Gene (Entity type)	ENSG00000276559 - bile acid-CoA:amino acid N-acyltransferase [Source:HGNC Symbol;Acc:HGNC:932]
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE186471 1 V 2 CARNOSOL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE168596 2 V 3 ADIPONECTIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE125956 SYK knockdown 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210655 3 V 2 CISPLATIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE213588 10 V 6 TRAMETINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

BAAT associations

Associations for BAAT_associations

BAAT associations.tsv

A file from IDG as part of the Harmonizome project

BAAT

ENSG00000136881 - bile acid-CoA:amino acid N-acyltransferase

BAAT

ENSG00000276559 - bile acid-CoA:amino acid N-acyltransferase [Source:HGNC Symbol;Acc:HGNC:932]

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE186471 1 V 2 CARNOSOL HUMAN DN

A Gene Set from LINCS

GSE168596 2 V 3 ADIPONECTIN MOUSE DN

A Gene Set from LINCS

GSE125956 SYK knockdown 4 v 2 human up

A Gene Set from LINCS

GSE210655 3 V 2 CISPLATIN MOUSE UP

A Gene Set from LINCS

GSE213588 10 V 6 TRAMETINIB HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.